Adjuvia Therapeutics Secures $8 Million in Latest Seed Funding Round

Adjuvia Therapeutics secured $8 million in its latest Seed, adding another data point to the Healthcare & Life Sciences funding market.

Adjuvia Therapeutics Raises $8 million in Funding

Adjuvia Therapeutics Raises $8 Million Seed Round to Advance ATI-105 Into Clinical Trials. COMPANIES THAT TRUST citybiz Search for: cities channels citybiz+ q&as interviews

Investors Behind the Funding

The round was backed by JLO Ventures. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Adjuvia Therapeutics operates in Healthcare & Life Sciences. Adjuvia Therapeutics's financing adds to recent private-market activity.

Strategic Use of Funds

Advance ATI-105 Into Clinical Trials.

Looking Ahead

This financing marks an important milestone for Adjuvia as we prepare to bring ATI-105 into the clinic,

Source reference: original announcement/article.